John Shern

32PUBLICATIONS

314CO-AUTHORS

Molecular targetsCellular nervous systemSolid tumoursGene and molecular therapyNeurology and neuromuscular diseases

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (32)

Sort by Publication Date:

|Jul 14, 2026

CDK8 Inhibition Releases the Muscle Differentiation Block in Fusion-driven Alveolar Rhabdomyosarcoma.

|May 28, 2026

Fusion-positive rhabdomyosarcoma oncofusions share a common interactome.

|Apr 22, 2026

NAPRT expression and epigenetic regulation in pediatric rhabdomyosarcoma as a potential biomarker for NAMPT inhibition.

|Mar 28, 2026

Biological Advances and Current Challenges for Pediatric Rhabdomyosarcoma.

Katie E Hebron, Patience Odeniyide, Yun Wei

|Jan 08, 2026

SARC031: A Phase II Trial of Selumetinib and Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors (MPNST).

AeRang Kim, Karla V Ballman, Pamela L Wolters

|Dec 04, 2025

Activity of Direct KRAS(G12C) Inhibitors in Preclinical Models of Pediatric Cancer.

Hannah E Price, Stacey Stauffer, Hyun Lee

Pageof 6

Frequent Collaborators

R Taylor Sundby

Marielle Yohe

Brigitte Widemann

Eva Dombi

Haiyan Lei

Angela C Hirbe

Christine M Heske

Javed Khan

Xiyuan Zhang

Carol J Thiele

Frequent Collaborators

R Taylor Sundby

Marielle Yohe

Brigitte Widemann

Eva Dombi